Curex Life Science Fund, LP

Amendment
CIK: 0001789886·Pooled Investment Fund·DELAWARE·Filed: Dec 13, 2021
Total Offering

Indefinite

Amount Sold

$9,175,395

Investors

30

First Sale

Dec 3, 2019

Offering Details

Type
Equity, Pooled Investment Fund
Exemptions
Rule 506(b), Section 3(c), Section 3(c)(1)
Entity Type
Limited Partnership
Year Incorporated
2019
Non-Accredited Investors
No

Related Persons

NameRole
Joshua Trantum
Related Person
Keith Ferrari
Related Person

Company

Curex Life Science Fund, LP

8200 HWY 100

NASHVILLE, TN, 37221

(629) 202-8149

SEC Filing

0001789886-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Curex Life Science Fund, LP Form D Filing — Indefinite | FilingFlow